Cardiovascular and renal phenotyping of genetically modified mice: A challenge for traditional physiology

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 4, 2003, Pages 207-216

  Fitzgerald, Sharyn M ^a,b   Gan, Liming ^a   Wickman, Anna ^a   Bergström, Göran ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cardiovascular system; Renal function; Resting metabolic rate; Transgenic mice; Vascular reactivity

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADRENERGIC RECEPTOR; ALBUMIN; ALDOSTERONE; ANGIOTENSINOGEN; APOLIPOPROTEIN E; ATIPAMEZOLE; ATRIAL NATRIURETIC FACTOR; BRADYKININ; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; ELECTROLYTE; HALOTHANE; HORMONE; ISOPRENALINE; KETAMINE; KININOGEN; LOW DENSITY LIPOPROTEIN RECEPTOR; MEDETOMIDINE; MYOGLOBIN; MYOSIN BINDING PROTEIN C; NITRIC OXIDE SYNTHASE; OXYGEN; PENTOBARBITAL; PROTEIN; RENIN; TRANSCRIPTION FACTOR; XYLAZINE;

ANESTHESIA; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR SYSTEM; CREATININE CLEARANCE; DIET; DNA MODIFICATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EMOTIONAL STRESS; EXERCISE; GENE MUTATION; GENETIC ENGINEERING; GENOTYPE; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART RATE VARIABILITY; KIDNEY; KIDNEY FUNCTION; METABOLIC RATE; MOLECULAR BIOLOGY; NONHUMAN; PHENOTYPE; PLETHYSMOGRAPHY; POLYMERASE CHAIN REACTION; PROVOCATION TEST; SHORT SURVEY; TRANSGENIC MOUSE; VAGUS TONE; VASCULAR RESISTANCE;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGY; DISEASE MODELS, ANIMAL; GENETIC ENGINEERING; GENOTYPE; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; KIDNEY; KIDNEY FUNCTION TESTS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL; PHENOTYPE;

EID: 0037391419     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03818.x     Document Type: Short Survey

References (73)

1. Hulander M, Wurst W, Carlsson P, Enerback S. The winged helix transcription factor Fkh10 is required for normal development of the inner ear. Nat. Genet. 1998; 20: 374-6.
2. Brown SD, Peters J. Combining mutagenesis and genomics in the mouse: Closing the phenotype gap. Trends Genet. 1996; 12: 433-5.
3. Rao S, Verkman AS. Analysis of organ physiology in transgenic mice. Am. J. Physiol. Cell Physiol. 2000; 279: C1-18.
4. Carlson SH, Wyss JM. Long-term telemetric recording of arterial pressure and heart rate in mice fed basal and high NaCl diets. Hypertension 2000; 35: E1-5.
5. Bohlooly YM, Carlson L, Olsson B et al. Vascular function and blood pressure in GH transgenic mice. Endocrinology 2001; 142: 3317-23.
6. Mattson DL. Comparison of arterial blood pressure in different strains of mice. Am. J. Hypertens. 2001; 14: 405-8.
7. Chaves AA, Weinstein DM, Bauer JA. Non-invasive echocardiographic studies in mice: Influence of anesthetic regimen. Life Sci. 2001; 69: 213-22.
8. Schlager G. Systolic blood pressure in eight inbred strains of mice. Nature 1966; 212: 519-20.
9. Mattson DL. Long-term measurement of arterial blood pressure in conscious mice. Am. J. Physiol. 1998; 274: R564-70.
10. Li P, Sur SH, Mistlberger RE, Morris M. Circadian blood pressure and heart rate rhythms in mice. Am. J. Physiol. 1999; 276: R500-4.
11. Mattson DL, Krauski KR. Chronic sodium balance and blood pressure response to captopril in conscious mice. Hypertension 1998; 32: 923-8.
12. Janssen BJ, Smits JF. Autonomic control of blood pressure in mice: Basic physiology and effects of genetic modification. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002: 282: R1545-64.
13. Van Vliet BN, Chafe LL, Antic V, Schnyder-Candrian S, Montani JP. Direct and indirect methods used to study arterial blood pressure. J. Pharmacol. Toxicol. Methods 2000; 44: 361-73.
14. Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: A predictor of sudden cardiac death. Circulation 1982; 66: 874-80.
15. Bigger Jr JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85: 164-71.
16. La Rovere MT, Bigger Jr JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478-84.
17. Gehrmann J, Hammer PE, Maguire CT, Wakimoto H, Triedman JK, Berul CI. Phenotypic screening for heart rate variability in the mouse. Am. J. Physiol. Heart Circ. Physiol. 2000; 279: H733-40.
18. Mansier P, Medigue C, Charlotte N et al. Decreased heart rate variability in transgenic mice overexpressing atrial beta 1-adrenoceptors. Am. J. Physiol. 1996; 271: H1465-72.
19. Desai KH, Sato R, Schauble E, Barsh GS, Kobilka BK, Bernstein D. Cardiovascular indexes in the mouse at rest and with exercise: New tools to study models of cardiac disease. Am. J. Physiol. 1997; 272: H1053-61.
20. Wickman K, Nemec J, Gendler SJ, Clapham DE. Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 1998; 20: 103-14.
21. Just A, Faulhaber J, Ehmke H. Autonomic cardiovascular control in conscious mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000; 279: R2214-21.
22. Oh-hashi Y, Shindo T, Kurihara Y et al. Elevated sympathetic nervous activity in mice deficient in alphaCGRP. Circ. Res. 2001; 89: 983-90.
23. Berul CI. Aronovitz MJ. Wang PJ, Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation 1996; 94: 2641-8.
24. Doevendans PA, Daemen MJ, de Muinck ED, Smits JF. Cardiovascular phenotyping in mice. Cardiovasc. Res. 1998; 39: 34-49.
25. Field LJ. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science 1988; 239: 1029-33.
26. Berul CI, Christe ME, Aronovitz MJ, Seidman CE, Seidman JG, Mendelsohn ME. Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice. J. Clin. Invest. 1997; 99: 570-6.
27. Caligiuri G, Levy B, Pernow J, Thoren P, Hansson GK. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc. Natl Acad. Sci. USA 1999; 96: 6920-4.
28. Wehrens XH, Kirchhoff S, Doevendans PA. Mouse electrocardiography: An interval of thirty years. Cardiovasc. Res. 2000; 45: 231-7.
29. Gehrmann J, Frantz S, Maguire CT et al. Electrophysiological characterization of murine myocardial ischemia and infarction. Basic Res. Cardiol. 2001; 96: 237-50.
30. Hoit BD. New approaches to phenotypic analysis in adult mice. J. Mol. Cell. Cardiol, 2001; 33: 27-35.
31. Barbee RW, Perry BD, Re RN, Murgo JP. Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice. Am. J. Physiol. 1992; 263: R728-33.
32. Champion HC, Villnave DJ, Tower A. Kadowitz PJ, Hyman AL. A novel right-heart catheterization technique for in vivo measurement of vascular responses in lungs of intact mice. Am. J. Physiol. Heart Circ. Physiol. 2000; 278: H8-15.
33. 2-adrenoceptors or with myocardial infarct. Clin. Exp. Pharmacol. Physiol. 2001; 28: 364-70.
34. Janssen B, Debets J, Leenders P, Smits J. Chronic measurement of cardiac output in conscious mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002; 282: R928-35.
35. Youn HJ, Rokosh G, Lester SJ, Simpson P, Schiller NB, Foster E. Two-dimensional echocardiography with a 15-MHz transducer is a promising alternative for in vivo measurement of left ventricular mass in mice. J. Am. Soc. Echocardiogr. 1999; 12: 70-5.
36. Hoit BD, Nadeau JH. Phenotype-driven genetic approaches in mice: High-throughput phenotyping for discovering new models of cardiovascular disease. Trends Cardiovasc. Med. 2001; 11: 82-9.
37. Oliverio MI, Delnomdedieu M, Best CF et al. Abnormal water metabolism in mice lacking the type 1A receptor for ANG II. Am. J. Physiol. Renal Physiol. 2000; 278: F75-82.
38. Katoh M, Ohmachi Y Kurosawa Y, Yoneda H, Tanaka N, Narita H. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice. Eur. J. Pharmacol. 2000; 398: 381-7.
39. Wang D, Yoshida H, Song Q, Chao L, Chao J. Enhanced renal function in bradykinin B(2) receptor transgenic mice. Am. J. Physiol. Renal Physiol. 2000; 278: F484-91.
40. Umemura S, Kihara M, Sumida Y et al. Endocrinological abnormalities in angiotensinogen-gene knockout mice: Studies of hormonal responses to dietary salt loading. J. Hypertens. 1998; 16: 285-9.
41. Meneton P, Ichikawa I, Inagami T, Schnermann J. Renal physiology of the mouse. Am. J. Physiol. Renal Physiol. 2000; 278: F339-51.
42. Downey P, Sapirstein A, O'Leary E, Sun TX, Brown D, Bonventre JV. Renal concentrating defect in mice lacking group IV cytosolic phospholipase A(2). Am. J. Physiol. Renal Physiol. 2001; 280: F607-18.
43. Aberbukh Z, Weissgarten J, Berman S et al. Effect of dietary manipulations on glomerular filtration rate of mice offspring of nephrectomized mothers. Am. J. Nephrol. 1993; 13: 190-3.
44. Tomobe K, Philbrick D, Aukema HM et al. Early dietary protein restriction slows disease progression and lengthens survival in mice with polycystic kidney disease. J. Am. Soc. Nephrol. 1994; 5: 1355-60.
45. Norwood VF, Morham SG, Smithies O. Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice. Kidney Int. 2000; 58: 2291-300.
46. Lorenz JN, Gruenstein E. A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin. Am. J. Physiol. 1999; 276: F172-7.
47. + transporter abundances in NHE3 and NCC null mice using targeted proteomics. J. Physiol. 2001; 530: 359-66.
48. Fentzke RC, Korcarz CE, Shroff SG et al. Evaluation of ventricular and arterial hemodynamics in anesthetized closed-chest mice. J. Am. Soc. Echocardiogr. 1997; 10: 915-25.
49. Mulvany MJ. Resistance vessel structure and function in the etiology of hypertension studied in F2-generation hypertensive-normotensive rats. J. Hypertens. 1988; 6: 655-63.
50. Yang R, Powell-Braxton L, Ogaoawara AK et al. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 1999; 19: 2762-8.
51. Gan L, Miocic M, Doroudi R, Selin-Sjogren L, Jern S. Distinct regulation of vascular endothelial growth factor in intact human conduit vessels exposed to laminar fluid shear stress and pressure. Biochem. Biophys. Res. Commun. 2000; 272: 490-6.
52. Gan L, Sjogren LS, Doroudi R, Jern S. A new computerized biomechanical perfusion model for ex vivo study of fluid mechanical forces in intact conduit vessels. J. Vasc. Res. 1999; 36: 68-78.
53. Lichtenbeld HC, Yuan F, Michel CC, Jain RK. Peffusion of single tumor microvessels: Application to vascular permeability measurement. Microcirculation 1996; 3: 349-57.
54. Chruscinski A, Brede ME, Meinel L, Lohse MJ, Kobilka BK, Hein L. Differential distribution of beta-adrenergic receptor subtypes in blood vessels of knockout mice lacking beta(1)- or beta(2)-adrenergic receptors. Mol. Pharmacol. 2001; 60: 955-62.
55. Peng H, Matchkov V, Ivarsen A, Aalkjaer C, Nilsson H. Hypothesis for the initiation of vasomotion. Circ. Res. 2001; 88: 810-15.
56. Gan L, Doroudi R, Hagg U, Johansson A, Selin-Sjogren L, Jern S. Differential immediate-early gene responses to shear stress and intraluminal pressure in intact human conduit vessels. FEBS Lett. 2000; 477: 89-94.
57. Chruscinski AJ, Rohrer DK, Schauble E, Desai KH, Bernstein D, Kobilka BK. Targeted disruption of the beta2 adrenergic receptor gene. J. Biol. Chem. 1999; 274: 16 694-700.
58. Yang Q, Osinska H, Klevitsky R, Robbins J. Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains. J. Mol. Cell. Cardiol. 2001; 33: 1649-58.
59. Schreyer SA, Wilson DL, LeBoeuf RC. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 1998; 136: 17-24.
60. Johansson C, Vennstrom B, Thoren P. Evidence that decreased heart rate in thyroid hormone receptor-alphal-deficient mice is an intrinsic defect. Am. J. Physiol. 1998; 275: R640-6.
61. Kuhlencordt PJ, Gyurko R, Han F et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001; 104: 448-54.
62. Williams RS, Benjamin IJ. Protective responses in the ischemic myocardium. J. Clin. Invest. 2000; 106: 813-18.
63. 2+ homeostasis and cardiomyocyte function. J. Biol. Chem. 2000; 275: 38 073-80.
64. Sigmund CD. Viewpoint: Are studies in genetically altered mice out of control? Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1425-9.
65. Nishina PM, Naggert JK, Verstuyft J, Paigen B. Atherosclerosis in genetically obese mice: The mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 1994; 43: 554-8.
66. Cederberg A, Gronning LM, Ahren B, Tasken K, Carlsson P, Enerback S. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 2001; 106: 563-73.
67. Harkness JE, Wagner JE. The Biology and Medicine of Rabbits and Rodents. Lea & Febiger, Philadelphia. 1989.
68. Guyton AC, Hall JE. Textbook of Medical Physiology. Saunders, Philadelphia. 2000.
69. Krinke GJ. The Laboratory Rat. Academic Press, San Diego. 2000.
70. Sharp PE, La Regina MC. The Laboratory Rat. CRC Press, Boca Raton. 1998.
71. Kass DA, Hare JM, Georgakopoulos D. Murine cardiac function: A cautionary tail. Circ. Res. 1998; 82: 519-22.
72. Kline DD, Yang T, Huang PL, Prabhakar NR. Altered respiratory responses to hypoxia in mutant mice deficient in neuronal nitric oxide synthase. J. Physiol. 1998; 511: 273-87.
73. Green E. Biology of the Laboratory Mouse. Dover Publications, New York. 1966.